PR: Allegiance - Cing-X Corp funded by Collagenna

PR: Allegiance -> Cing-X Corp funded by Collagenna and Legacy Research Corp.

http://www.accesswire.com/viewarticle.aspx?id=399614
The Cing-X Corporation Established To Market Cing-X Capsules

10/23/2012 [ACCESSWIRE]

TORONTO -- Allegiance Equity Corporation (TSXV:ANQ.V) is pleased to announce Legacy Research Corporation (Legacy) and Collagenna Skin Care Products Inc (Collagenna) funded The CING-X Corporation to market CING-X Capsules.

Allegiance and Legacy each own a 25% equity share ownership in The CING-X CORPORATION‘ in partnership with Collagenna. The new arrangements will achieve substantially greater revenues for Allegiance.

COLLAGENNA ACTIVELY MARKETING OF CING-X CAPSULES

Collagenna Skin Care Inc. initiated marketing activities with very promising results. Over 50 health food stores and chains in Canada have been contacted to date and we expect to get immediate product placement once the capsules become available November 15, 2012. One unsolicited order of 300 bottles for a small Health Food chain has been received.

In the United States, the reception has also been very productive . THE CING-X CORPORATION has been approached by several distribution groups and the company is presently in discussions with one group that specializes in direct distribution to Drug stores, pharmacies and health food stores via the use of over 30 sales representatives. This group has been in business for 35 years and has access to more than 30,000 retail units not including the big box stores. Discussions are ongoing and a proposal for a distribution agreement is imminent.

A bottle of 60 capsules is projected to sell at a retail value of $39.

ABOUT CING-X

CING-X(TM), is a combination of standardized extracts acting synergistically to control glucose metabolism, and improve, cognitive function and simultaneously reduce the risk of developing and treating conditions associated with blood glucose metabolism and brain function.

CING-X(TM) meets FDA and all other North American regulatory requirements including those of the FDA. And has received favorable review from the PCT International Patent Examiner.

[More: Allegiance Equity details.]